BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35363220)

  • 1. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
    Nesteruk K; Levink IJM; Dits NFJ; Cahen DL; Peppelenbosch MP; Bruno MJ; Fuhler GM
    Clin Transl Gastroenterol; 2022 Feb; 13(3):e00465. PubMed ID: 35363220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer.
    Levink IJM; Visser IJ; Koopmann BDM; van Driel LMJW; Poley JW; Cahen DL; Bruno MJ; Fuhler GM
    Gastrointest Endosc; 2022 Nov; 96(5):801-813.e2. PubMed ID: 35537661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X; Bhandari K; Xu C; Morris K; Ding WQ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma.
    Odaka H; Hiemori K; Shimoda A; Akiyoshi K; Tateno H
    BMC Gastroenterol; 2022 Mar; 22(1):153. PubMed ID: 35350978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.
    Yoshioka Y; Shimomura M; Saito K; Ishii H; Doki Y; Eguchi H; Nakatsura T; Itoi T; Kuroda M; Mori M; Ochiya T
    Cancer Sci; 2022 Oct; 113(10):3498-3509. PubMed ID: 35848896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Isolation Method for Extracellular Vesicles from Pancreatic Juice and Impact of Protease Activity.
    Tsutsumi K; Ueta E; Kato H; Matsumoto K; Horiguchi S; Okada H
    Dig Dis Sci; 2022 Oct; 67(10):4797-4804. PubMed ID: 35037137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
    Inoue H; Eguchi A; Kobayashi Y; Usugi E; Yamada R; Tsuboi J; Akuta T; Horiki N; Iwasa M; Takei Y
    J Hepatobiliary Pancreat Sci; 2022 Mar; 29(3):394-403. PubMed ID: 34555251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
    Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
    Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
    Roy JW; Wajnberg G; Ouellette A; Boucher JE; Lacroix J; Chacko S; Ghosh A; Ouellette RJ; Lewis SM
    Sci Rep; 2023 Jun; 13(1):9251. PubMed ID: 37286718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
    J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
    Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T
    Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
    Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
    Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
    PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer.
    Sarkar R; Xu Z; Perera CJ; Apte MV
    Semin Cancer Biol; 2023 Aug; 93():114-122. PubMed ID: 37225047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids.
    Buenafe AC; Dorrell C; Reddy AP; Klimek J; Marks DL
    Sci Rep; 2022 Mar; 12(1):3556. PubMed ID: 35241737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer.
    Asada T; Nakahata S; Fauzi YR; Ichikawa T; Inoue K; Shibata N; Fujii Y; Imamura N; Hiyoshi M; Nanashima A; Morishita K
    Anticancer Res; 2022 Apr; 42(4):1763-1775. PubMed ID: 35346995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG
    Couto N; Elzanowska J; Maia J; Batista S; Pereira CE; Beck HC; Carvalho AS; Strano Moraes MC; Carvalho C; Oliveira M; Matthiesen R; Costa-Silva B
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic adenocarcinoma.
    Vikramdeo KS; Anand S; Khan MA; Khushman M; Heslin MJ; Singh S; Singh AP; Dasgupta S
    Sci Rep; 2022 Nov; 12(1):18455. PubMed ID: 36323735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T
    Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.